Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center
Clinical trials sponsored by Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center, explained in plain language.
-
Finding the right rhythm: how often should bladder therapy continue?
Disease control CompletedThis study aimed to find the best way to maintain the benefits of a nerve stimulation treatment for overactive bladder. Researchers compared giving the therapy monthly to giving it only when patients felt their symptoms returning. The goal was to see if a flexible, as-needed sche…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Apr 02, 2026 06:11 UTC
-
Study tests which pill works best for stubborn skin boils
Disease control CompletedThis study aimed to find the better antibiotic for common skin infections like boils and cellulitis. Researchers compared two widely used pills, doxycycline and trimethoprim-sulfamethoxazole (TMP-SMX), in 269 outpatients. The goal was to see which drug was more effective at curin…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Common overdose drug tested as potential stroke treatment
Disease control CompletedThis study tested whether giving an intravenous antioxidant drug called N-acetylcysteine (NAC) could help people recover better after a stroke. NAC is already FDA-approved for treating acetaminophen overdose. The trial involved 4 adults who had a recent ischemic stroke and were n…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Doctors test new talk strategy to stop unhelpful ICU treatments
Disease control CompletedThis study tested if a new communication strategy could reduce aggressive, unhelpful treatments for very sick patients in the intensive care unit (ICU). Doctors and families agreed to try treatments for a set time to see if the patient improved, aiming to avoid prolonged sufferin…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists test daily pill for men to prevent pregnancy
Prevention CompletedThis early-stage study tested the safety of a new experimental pill called DMAU, intended for use as a male contraceptive. Researchers gave the pill to 100 healthy men, first as a single dose and then daily for 28 days, to check for side effects and see how the body processes it.…
Phase: PHASE1 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Prevention
Last updated Mar 18, 2026 14:41 UTC
-
Study aims to stop infant obesity before it starts
Prevention CompletedThis study tested whether carefully adjusting the amount of milk or formula given to babies could prevent them from becoming overweight by 6 months of age. It focused on infants born to mothers who were overweight or obese, as these babies are at higher risk for early weight gain…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Prevention
Last updated Mar 16, 2026 15:24 UTC
-
Home therapy offers new hope for bladder control issues
Symptom relief CompletedThis study tested whether an at-home nerve stimulation treatment for overactive bladder is as effective and satisfying for patients as the clinic-based version. Researchers compared 70 patients who either received weekly clinic treatments or learned to do treatments themselves at…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:14 UTC
-
Scientists probe Sleep's hidden link to diabetes
Knowledge-focused CompletedThis study aimed to understand how not getting enough sleep might lead to insulin resistance, a key factor in type 2 diabetes. Researchers studied 40 healthy men by restricting their sleep and measuring changes in hormones like cortisol and testosterone. The goal was to gather kn…
Phase: EARLY_PHASE1 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC